Product-photo-based composite with an illustrative ingredient setting. Confirm the offered grade and supporting supplier documentation.
Qualify a bulk spirulina supplier by agreeing on the ingredient specification, verifying the manufacturing source, checking the reliability of supporting test results, and documenting a quality approval before commercial use. A competitive quotation and a sample that performs well are useful starting points; approval also needs evidence that future shipments can be controlled.
Start with your intended product and market
Tell the supplier whether the material is intended for capsules, tablets, a blended powder, or another application. State the destination market, expected consumption, processing conditions, packaging needs, and required documentation. These details help purchasing and QA agree on what must be reviewed before the first order.
For U.S. supplement manufacturers, FDA’s guidance distinguishes a dietary ingredient business from a finished supplement operation; regulatory coverage depends on the activities performed. Do not treat every upstream ingredient supplier as having identical obligations. FDA’s dietary supplement CGMP guide explains that distinction.
Confirm who makes the material
Request the legal supplier name, manufacturing site, country of manufacture, ingredient identity, and a description of the supplied form. If a distributor is involved, establish how its lot numbers connect to the original manufacturer. Ask who handles technical questions, deviations, complaints, and recalls. A certificate bearing a trading company’s name does not by itself establish the production source.
Build a specification that QA can release against
Create a controlled specification rather than collecting unrelated certificates. For a U.S. dietary supplement manufacturer, 21 CFR 111.70(b) requires component identity specifications, other specifications needed to support finished-supplement purity, strength and composition, and limits on contamination that may adulterate the finished batch. Translate these requirements into a controlled purchasing specification. For spirulina, the review may include microbiological quality, elemental contaminants, and cyanotoxin controls, alongside moisture, protein reporting basis, particle size, and application requirements. Agree on methods, units, acceptance criteria, and the document revision.
| Qualification question | Evidence to request | Decision it supports |
|---|---|---|
| Is this the agreed ingredient? | Identity documentation and a suitable test or examination | Material identification |
| Are results comparable? | Method, reporting basis, limits, actual lot results | Specification assessment |
| Can a shipment be traced? | Manufacturer-to-delivery lot mapping | Investigation and recall readiness |
| Will changes be communicated? | Written notification process and named contacts | Continued qualification |
Verify the evidence behind supplier results
Under 21 CFR 111.75, a supplement manufacturer generally must perform an appropriate identity test or examination for a dietary ingredient unless FDA grants an exemption. Reliance on a supplier COA for other applicable specifications has conditions: establish its reliability by confirming results, keep qualification records, periodically reconfirm, and obtain QC approval. The COA must describe methods, limits, and actual results. Supplier approval does not remove the manufacturer’s identity responsibility.
As a practical implementation, QA can define which lots and attributes to compare with an independent laboratory, how to investigate disagreement, and what triggers additional review. Choose laboratories and methods suited to the ingredient and analytes. Accreditation is useful supporting evidence when its scope covers the work; it does not answer every method-suitability question.
Separate technical approval from commercial approval
Run the sample through the intended process and record flow, blending, sensory performance where relevant, and packaging compatibility. Separately confirm lead time, order size, shelf-life documentation, transport conditions, and supply continuity. A sample can pass formulation trials while the supplier file remains incomplete. Keep the approval status explicit so an attractive sample does not become an unintended purchasing release.
Keep the supplier qualified after the first shipment
A useful quality agreement specifies notification expectations for site, process, raw-material source, method, formulation, and packaging changes. Define who reviews deviations and when approval must be revisited. Track incoming-lot issues and document the basis for continued use. Audit depth and review frequency should reflect the actual risk and performance history rather than an arbitrary universal interval.
For your next AimGrow sourcing discussion, prepare the target specification, application, destination market, and evidence gaps. Ask for documents and a representative sample for QA review before committing to production use.
Review the AimGrow spirulina powder product page and contact AimGrow to discuss the current specification and your documentation needs.